Skip to Content

niraparib 100 mg (Zejula 100 mg)

Generic Name: niraparib

Pill with imprint niraparib 100 mg is Purple / White, Capsule-shape and has been identified as Zejula 100 mg. It is supplied by Tesaro Inc..

Zejula is used in the treatment of peritoneal cancer; ovarian cancer; fallopian tube cancer and belongs to the drug class PARP inhibitors. Zejula 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for niraparib 100 mg

Zejula

Generic Name:
niraparib
Imprint:
niraparib 100 mg
Strength:
100 mg
Color:
Purple / White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
PARP inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Tesaro Inc.
National Drug Code (NDC):
69656-0103

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide